Racial Differences and Temporal Trends in Parkinson’s and Alzheimer’s Disease-Related

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objective

The objectives of this study were to examine racial differences and temporal trends in Alzheimer’s disease (AD)- and Parkinson’s disease (PD)-related mortality among U.S. adults and to assess whether racial mortality patterns and temporal changes differed.

Methods

We analyzed CDC WONDER Multiple Cause of Death data from 2018-2024, where mortality was defined as deaths with AD or PD recorded as an underlying or contributing cause. Age-standardized mortality rates and adjusted mortality rate ratios (MRRs) were estimated. Joint-point regression evaluated racial differences, annual percentage changes (APCs), and disease-race-year interactions. Sensitivity analyses assessed the robustness of the findings.

Results

Black had significantly lower PD-related mortality than White (adjusted mortality rate ratios [MRRs]: 0.62-0.69; all p<0.001), whereas AD-related mortality showed no significant racial differences (MRRs: 0.91-1.06). Compared with 2018, mortality increased significantly in 2020 for both diseases among White adults (AD: MRR=1.21; PD: MRR=1.27) and Black adults (AD: MRR=1.27; PD: MRR=1.37), followed by partial declines. PD-related mortality increased significantly among White adults during 2018-2023 (annual percentage change [APC]=3.08%; 95% CI: 1.15%-5.05%), whereas trends among Black adults (APC=3.51%; 95% CI: -2.94% to 10.39%) and AD-related mortality trends in both racial groups were not statistically significant. The disease-race-year interaction was not significant (p=0.942), indicating insufficient evidence that temporal mortality patterns differed jointly.

Conclusions

Recorded PD-related mortality was lower among Black than White adults, whereas AD-related mortality showed no statistically significant racial difference. These findings support disease-specific mortality surveillance and further investigation of potential differences in diagnostic recognition and death-certificate documentation.

Article activity feed